We often talk about innovation in terms of science and technology, but in today’s healthcare ecosystem, it’s just as important to innovate on the business side of things.
That’s what the $250 million Harrington Project for Discovery & Development, a national initiative based at University Hospitals Case Medical Center, is trying to do. It comprises nonprofit and for-profit entities aimed at helping new developments in biotechnology cross the “valley of death,” which lately has become more of an “uncrossable canyon,” according to Baiju Shah, the CEO of BioMotiv, the for-profit side of the project.
To read the original article: The biotech valley of death has become the uncrossable canyon. Here’s one innovative approach to funding | MedCity News
